Red Cross Supports New Restrictions Against Mad Cow

Article

WASHINGTON, DC-The American Red Cross is worried about Mad Cow and its human variant, Creutzfeldt-Jakob disease, infecting American blood supplies.

The organization is supporting new measures that would prohibit people who have spent more than six months in England or France from donating. Researchers do not know if Mad Cow or vCJD is transmitted through blood; however, they are not willing to take the chance.

There is no test for the disease, and as a precaution US health officials already ban people from donating if they spend six months or more in Britain from 1990-1996. The Food and Drug Administration (FDA) is reviewing the policy Thursday and may change the time period from 1980 to the present.

American blood centers are currently dealing with one of the worst blood shortages in the past year. These latest regulations could decrease donations by an estimated 5-6%. Blood banks are calling out for eligible volunteers to donate.

Both Mad Cow and human variant Creutzfeldt-Jakob Disease remain mysterious. Their cause and origin are unknow, although scientists think both are caused by misfolded proteins called prions.

More than 80 people have died in Europe from vCJD.

Information from Reuters

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)